M22 vs BBL HERO: Which Light-Based Treatment May Suit Pigmentation, Redness and Sun Damage?

Clinical guidance from Dr Nyla Raja MBChB (Hons), MRCGP (Dist), DFFP, DPDermatology - GMC No. 6057913

M22 and BBL HEROic are advanced light-based treatments used for concerns such as uneven pigmentation, visible redness, sun damage, and broken capillaries. Neither is universally better. The more suitable option depends on what is causing the colour change, whether texture or deeper vessels are also involved, your skin type, treatment area, and the level of recovery you can accommodate.

Dr Nyla Medispa offers both platforms because they have different strengths. M22 is a multi-technology platform that can combine IPL photorejuvenation with ResurFX fractional laser resurfacing or an Nd:YAG laser for selected vascular concerns. BBL HEROic is a broadband light treatment designed to address diffuse pigmentation, redness, and visible sun damage efficiently, including across larger areas such as the chest, arms, back, or legs.

M22 vs BBL HEROic: the main difference

Both treatments use carefully selected wavelengths of light to target pigment or blood vessels in the skin. When pigment absorbs light, it can temporarily darken before gradually lifting away as the skin renews. When light is directed towards superficial vascular redness, it can help reduce the appearance of visible vessels and diffuse erythema.

The important distinction is that BBL HEROic is a broadband light platform, whereas M22 offers several technologies within one system. This gives M22 particular versatility when pigmentation or redness sits alongside textural change, fine lines, minor scarring, or selected deeper vascular concerns.

When M22 may be the more appropriate option

M22 may be particularly useful where the skin concern is not limited to superficial pigmentation or redness. Its IPL treatment can address sun spots, freckles, uneven tone, visible capillaries, and the appearance of redness associated with rosacea, while other M22 handpieces can be selected where texture or vascular depth requires a different approach.

For example, ResurFX is a non-ablative fractional laser treatment within the M22 platform. It may be considered when fine lines, enlarged pores, minor acne scarring, or uneven texture are important parts of the treatment goal. The Multi-Spot Nd:YAG laser may be considered for selected deeper vascular concerns, including some facial blood vessels and leg veins.

This does not mean every M22 appointment uses every modality. A treatment plan should be based on the specific concern, rather than adding technologies unnecessarily.

When BBL HEROic may be the more appropriate option

BBL HEROic may be a suitable option when the principal aim is improving the overall appearance of widespread sun-related colour changes, including mottled pigmentation, freckles, redness, broken capillaries, and an uneven-looking complexion. Its large treatment coverage and integrated cooling can also make it practical for larger areas where sun exposure has accumulated over time, such as the décolletage, shoulders, arms, hands, back, or legs.

It is often considered by patients seeking a non-surgical treatment with minimal interruption to their routine. After treatment, the skin may look temporarily flushed or feel warm. Pigmented areas can also become more noticeable before they fade, which is an expected part of the process for some patients.

For more detail about what happens after treatment, read our guide to BBL HEROic downtime and aftercare.

Pigmentation needs an accurate diagnosis first

“Pigmentation” is a broad term. Sun spots, freckles, post-inflammatory marks, melasma, and a changing pigmented lesion do not have the same cause, so they should not automatically be approached in the same way.

In particular, melasma can be persistent and recurrent. Light-based treatment may have a role for selected patients, but it requires careful planning because pigment can worsen or return if the skin becomes inflamed or is exposed to ultraviolet and visible light. The British Association of Dermatologists’ patient guidance on melasma emphasises the importance of consistent sun protection alongside any treatment plan.

Any new, changing, itchy, bleeding, crusting, or unusually coloured mole or mark should be assessed by a GP or dermatologist before cosmetic light treatment. The NHS guidance on moles explains the changes that warrant medical review.

What does the evidence tell us?

IPL and broadband-light treatments are established options for benign pigmentary and vascular concerns, but published evidence does not show that one named device is universally superior for every patient. A systematic review of IPL in dermatology found evidence supporting its use for conditions including telangiectasia, lentigines, rosacea, and melasma, while also noting that treatment parameters and indications need to be individualised.

For facial redness and rosacea, research suggests that IPL can improve erythema and visible vessels for some patients. However, a 2024 systematic review of IPL for rosacea found that study quality and treatment settings varied considerably. In practical terms, this means a course of treatment may help visible redness, but it does not cure rosacea or remove the need to manage triggers and any medical component of the condition.

It is also important not to treat marketing claims about a platform as a guarantee of an individual outcome. Skin response is influenced by the diagnosis, skin tone, extent of sun damage, hormonal factors, skincare, sun exposure, and whether a full course is clinically appropriate.

Safety, skin tone, and recovery

Temporary redness, warmth, mild swelling, sensitivity, and darkening of targeted pigment can occur after IPL or broadband light treatment. Recovery varies with the area treated, the settings used, and whether M22 IPL, ResurFX, or another modality has been selected.

Skin tone, recent tanning, photosensitising medication, active skin inflammation, and previous energy-based procedures should all be discussed before treatment. Appropriate patient selection, conservative parameter choice where needed, eye protection, and clear aftercare are essential. The MHRA guidance on lasers and intense light source systems highlights the importance of safe clinical processes when using these devices.

Daily broad-spectrum sun protection remains important after either treatment. It helps protect the skin while it recovers and reduces the likelihood of new sun-related pigmentation developing.

Questions to ask at your consultation

• What type of pigmentation or redness am I treating?
• Is the concern superficial, vascular, textural, or a combination?
• Would M22 IPL, ResurFX, Nd:YAG, or BBL HEROic best match that concern?
• How many sessions may be needed, and how far apart should they be?
• What temporary effects should I expect for my skin and treatment area?
• Do my current skincare products, medications, tanning history, or previous treatments affect suitability?

The key point

For diffuse pigmentation, redness, and sun damage, BBL HEROic may be appropriate when efficient, broad-area light treatment is the priority. M22 may be more suitable when the treatment plan needs to address multiple concerns at different skin depths, particularly where texture, scarring, or selected vascular concerns are also relevant. The best decision comes from identifying the skin concern accurately, then matching the technology and settings to the individual rather than choosing a device by name alone.